Challenges and Opportunities in AI Implementation

In this episode of Driving the Business of Science, Keith Parent, CEO of Court Square Group, talks with Catherine Lunardi, CEO of GENAIZ, about the challenges and opportunities of implementing Artificial Intelligence (AI) in life science companies. Catherine explains her company's Intelligent Automation solutions, particularly their data orchestration platform. They discuss their partnership, which began at an economic development forum in Massachusetts. Catherine shares her background in pharmaceuticals and the inspiration behind GENAIZ, emphasizing the importance of AI in streamlining data management. They highlight successful projects involving a cross-referencing tool for large document volumes and introduce GENAIZ's semantic search engine for literature reviews. GENAIZ offers a powerful Data Orchestration platform purpose-built for the life sciences industry. We empower Pharmaceutical Sponsors, CDMO’s, CROs, Hospitals, Clinical Trials, and Academic Labs to make their data “talk” fast using advanced, Intelligent Automation solutions. Our Intelligent Automated solutions break down silos across Regulatory, Quality, Laboratory, and R&D functions—streamlining processes, enhancing compliance, and accelerating decision-making.Driving the Business of Science is the podcast for clinical operations, IT, and business managers in the pharma, biotech, and medical device world.Bringing new products to market takes more than just great science. From R&D and clinical to regulatory and approval life science leaders require fit-for-purpose technology, processes, and partners at step.In the Driving the Business of Science podcast leaders from across the life science industry share real-world experiences and practical insights that will impact your business.Join host Keith Parent, serial life science CEO, as business leaders share experiences and insights on emerging challenges in the life science market.